Research Paper Volume 15, Issue 15 pp 7811—7830
A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma
Figure 1. Mutation landscape of PRG in ESCC. (A) The CNV variation frequency of 33 PRG in the ESCC cohort. The height of the column represented the alteration frequency. (B, C) The mutation frequency and classification of 33 PRG. (D) The location of CNV alteration of 33 PRG on 23 chromosomes in the ESCC cohort.